Pharma Stocks

Gland Pharma block deal: Fosun Pharma divests 99 lakh shares worth Rs 2,800 crore

Promoter Fosun Pharma on Friday sold 98.97 lakh shares, equivalent to around 6% equity, in Gland Pharma for an estimated…

Read More »

Takeda Pharmaceutical (TSE:4502) Wins MIMRYLO Approval, Is The Stock Still Trading At A Discount?

Takeda Pharmaceutical (TSE:4502) is back in focus after two recent announcements. The stock is reacting to U.S. approval of MIMRYLO…

Read More »

Block deal alert! Gland Pharma shares in focus as promoter Fosun to sell 5% stake for Rs 2,279 crore

Shares of Gland Pharma will be in focus on Friday after its promoter, Fosun Pharma Industrial, looks to divest a…

Read More »

Is Eisai (TSE:4523) Cheap After China Approved At Home Leqembi Dosing?

Eisai (TSE:4523) is back in focus after China’s National Medical Products Administration approved the Leqembi subcutaneous autoinjector as an initiation…

Read More »

Insiders Sold EQL Pharma At kr52.22, Meanwhile Stock Sits Near kr25.30

Despite the fact that EQL Pharma AB (publ)’s (STO:EQL) value has dropped 10% in the last week insiders who sold…

Read More »

Why Is Little Green Pharma (ASX:LGP) in Focus Among Cannabis Stocks?

Highlights Little Green Pharma confirmed a new group finance appointment shortly after its annual general meeting concluded The appointment follows…

Read More »

Correction: Zealand Pharma – Transactions related to share buy-back program (week 35, 2026)

Zealand Pharma Company announcement No. 45 / 2026 Correction: Zealand Pharma – Transactions related to share buy-back program (week 35,…

Read More »

Ascentage Pharma to Participate in Four Upcoming Investor Conferences

ASCENTAGE PHARMA GROUP INTERNATIONAL ROCKVILLE, Md., Sept. 02, 2026 (GLOBE NEWSWIRE) — Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855)…

Read More »

Does Rusfertide Royalty Deal And Guidance Upgrade Change The Bull Case For Royalty Pharma (RPRX)?

Royalty Pharma recently agreed to pay Zealand Pharma US$100,000,000 for rights to future royalties and milestones tied to rusfertide, an…

Read More »

Is Teva Pharmaceutical Industries (TEVA) Undervalued On Its FDA Filing News Or Already Fully Valued?

Teva Pharmaceutical Industries (NYSE:TEVA) is in focus after the U.S. FDA accepted its New Drug Application for ecopipam, a potential…

Read More »